These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33761344)

  • 1. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.
    Brouwers B; de Oliveira EM; Marti-Solano M; Monteiro FBF; Laurin SA; Keogh JM; Henning E; Bounds R; Daly CA; Houston S; Ayinampudi V; Wasiluk N; Clarke D; Plouffe B; Bouvier M; Babu MM; Farooqi IS; Mokrosiński J
    Cell Rep; 2021 Mar; 34(12):108862. PubMed ID: 33761344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.
    Lotta LA; Mokrosiński J; Mendes de Oliveira E; Li C; Sharp SJ; Luan J; Brouwers B; Ayinampudi V; Bowker N; Kerrison N; Kaimakis V; Hoult D; Stewart ID; Wheeler E; Day FR; Perry JRB; Langenberg C; Wareham NJ; Farooqi IS
    Cell; 2019 Apr; 177(3):597-607.e9. PubMed ID: 31002796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
    Shinyama H; Masuzaki H; Fang H; Flier JS
    Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.
    Rodríguez Rondón AV; Welling MS; van den Akker ELT; van Rossum EFC; Boon EMJ; van Haelst MM; Delhanty PJD; Visser JA
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2452-2466. PubMed ID: 38567654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to α-melanocyte-stimulating hormone (α-MSH).
    McDaniel FK; Molden BM; Mohammad S; Baldini G; McPike L; Narducci P; Granell S; Baldini G
    J Biol Chem; 2012 Jun; 287(26):21873-90. PubMed ID: 22544740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
    Mo XL; Tao YX
    Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
    Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.
    Breit A; Wolff K; Kalwa H; Jarry H; Büch T; Gudermann T
    J Biol Chem; 2006 Dec; 281(49):37447-56. PubMed ID: 17041250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-associated mutant melanocortin-4 receptors with normal Gα
    Gillyard T; Fowler K; Williams SY; Cone RD
    J Neuroendocrinol; 2019 Oct; 31(10):e12795. PubMed ID: 31529534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.
    Wang XH; Wang HM; Zhao BL; Yu P; Fan ZC
    J Mol Endocrinol; 2014 Aug; 53(1):17-29. PubMed ID: 24780838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity.
    René P; Le Gouill C; Pogozheva ID; Lee G; Mosberg HI; Farooqi IS; Valenzano KJ; Bouvier M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):520-32. PubMed ID: 20826565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
    Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R
    J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity.
    René P; Lanfray D; Richard D; Bouvier M
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2.
    Piechowski CL; Rediger A; Lagemann C; Mühlhaus J; Müller A; Pratzka J; Tarnow P; Grüters A; Krude H; Kleinau G; Biebermann H
    J Mol Endocrinol; 2013; 51(1):109-18. PubMed ID: 23674133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance.
    Gavini CK; Cook TM; Rademacher DJ; Mansuy-Aubert V
    Metabolism; 2020 Jan; 102():153990. PubMed ID: 31666192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid stress inhibits endocytosis of melanocortin-4 receptor from modified clathrin-enriched sites and impairs receptor desensitization.
    Cooney KA; Molden BM; Kowalczyk NS; Russell S; Baldini G
    J Biol Chem; 2017 Oct; 292(43):17731-17745. PubMed ID: 28878020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
    Tao YX
    Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2.
    Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I
    Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
    Kleinau G; Heyder NA; Tao YX; Scheerer P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene.
    He S; Tao YX
    Int J Biol Sci; 2014; 10(10):1128-37. PubMed ID: 25332687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.